Page last updated: 2024-11-07

alpha-ketocaproic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-ketocaproic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-oxohexanoic acid : A straight-chain fatty acid consisting of hexanoic acid having an oxo group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID159664
CHEMBL ID3247426
CHEBI ID17308
SCHEMBL ID60653
MeSH IDM0042321

Synonyms (32)

Synonym
2-keto-n-caproic acid
2-oxo c6:0
CHEBI:17308 ,
alpha-ketohexanoic acid
2-ketohexanoic acid
2-oxo 6:0
2-oxohexanoic acid
2492-75-3
C00902
alpha-ketocaproic acid
LMFA01060007
2-oxo-hexanoic acid
AKOS006221009
hexanoic acid, 2-oxo-
CHEMBL3247426
SCHEMBL60653
XNIHZNNZJHYHLC-UHFFFAOYSA-N
2-oxo-n-hexanoic acid
DTXSID70179631
2-keto-n-caproate
2-oxo-hexanoate
2-ketocaproic acid
7n5 ,
E74594
CS-0069654
Q27102314
2-oxohexanoic'acid
AMY6080
BS-48482
CAA49275
2-oxohexanoicacid
EN300-120421

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In an attempt to demonstrate a possible dose-response relationship for ketoleucine, the postoperative protein breakdown (using urinary excretion of 3-methylhistidine, creatinine and nitrogen) was evaluated in 29 patients undergoing gynaecological surgery."( [Inhibition of postoperative muscular proteolysis by sodium alpha-ketoisocaproate: does a dose-effect relation exist?].
Blanc, M; Calderon, A; François, G; Lena, P; Rose, F, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human blood serum metaboliteAny metabolite (endogenous or exogenous) found in human blood serum samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
2-oxo monocarboxylic acidAny monocarboxylic acid having a 2-oxo substituent.
oxo fatty acidAny fatty acid containing at least one aldehydic or ketonic group in addition to the carboxylic acid group.
medium-chain fatty acidAny fatty acid with a chain length of between C6 and C12.
straight-chain fatty acidAny fatty acid whose skeletal carbon atoms form an unbranched open chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1130306Inhibition of glycolic acid oxidase (unknown origin) assessed as enzyme-mediated reduction of NaDCIP by sodium glycolate after 1 to 3 mins by spectrophotometer analysis1979Journal of medicinal chemistry, Jun, Volume: 22, Issue:6
Quantitative structure-activity relationships involving the inhibition of glycolic acid oxidase by derivatives of glycolic and glyoxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (47.37)18.7374
1990's8 (42.11)18.2507
2000's1 (5.26)29.6817
2010's1 (5.26)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.23 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]